AI trade recovery hinges on lower oil and dollar, hyperscaler capex confirmation, neocloud stabilization, and a successful ...

Markets feel like 1999 valuations with 2007-style credit cracks with VIX spikes, AI debt risks, and CRE distress. Read what ...

Mercedes-Benz remains a Buy: The stock trades at just 6.4x expected 2027 earnings, offering an attractive entry point despite ...

Ameriprise (AMP) was double downgraded by BofA on rising advisor departures, cutting its price target to $445.

CoreWeave (CRWB) stock jumps on Goldman Sachs upgrade to Buy, citing stronger contract economics, higher ARR/MW and IRR ...

Disc Medicine (IRON) stock is set to jump after a Phase 3 trial win for lead asset developed with Roche (RHHBY) for ...

Berkshire has been aggressively buying shares in homebuilders, accumulating shares of the homebuilding giant LEN, apparently ...

Edison International wildfire liability risk may cap upside and strain cash flow despite a 6.3% yield. Click here to read ...

Morgan Stanley upgrades Global-e (GLBE) to Overweight, citing durable DTC e-commerce same-store sales and upside catalysts.

Vaxcyte is a late clinical-stage vaccine company positioned as a potential disruptor in the vaccine market. Learn more about ...

France’s fiscal crisis and riots are rattling markets—see what it means for EU debt risk, bonds, and stocks, plus today’s key ...